Abstract:Objective:To investigate the clinical and genetic characteristics of genetic and metabolic infantile cholestatic hepatopathy (ICH), and to provide evidence for its diagnosis and treatment.Methods:Clinical data and follow-up outcomes of hospitalized children diagnosed with ICH in the Department of Gastroenterology, Children′s Hospital, Capital Institute of Pediatrics from January 2014 to December 2019 were retrospectively analyzed.Among the 80 children, 27 were female and 53 were male, with a mean age of onset of (39±18) days old.Children with confirmed etiology by high-throughput sequencing analysis were included in the genetic metabolic group (44 cases), and those with idiopathic neonatal cholestasis(INC) of unknown etiology after the systematic examination were included in the INC group (36 cases). The t-test or independent sample rank sum test was used to compare the laboratory test results and biochemical indexes.The infection rate of cytomegalovirus was compared by the Chi- square test. Results:(1) A total of 80 cases were included, and 44 cases (55.0%)were confirmed as INC by high-throughput sequencing.Among those with a positive molecular diagnosis, there were 23 cases of citrin deficiency (CD), 10 cases of Alagille syndrome (ALGS), 6 cases of progressive familial intrahepatic cholestasis (PFIC), 2 cases of congenital bile acid synthesis defect, 2 cases of Nieman Pick disease, and 1 case of cystic fibrosis.(2) Serum total bile acid (TBA) and activated partial prothrombin time (APTT) levels in the genetic metabolic group were significantly higher than those in the INC group (all P<0.05). TBA and APTT levels in genetic metabolites were 180.6 (115.5, 271.6) μmol/L and 40.6 (37.1, 45.2) s, respectively, which were 123.3 (98.8, 163.4) μmol/L and 34.8 (31.7, 40.1) s in INC group, respectively.There was no significant difference in the cytomegalovirus infection rate between the 2 groups ( P>0.05). (3)The pathological examination of liver tissue in the genetic metabolic group was worse than that in the INC group, with spot-like and fusion focal-like necrosis, and 5 cases (4 cases of ALGS and 1 case of CD) showed a reduced number of bile ducts in the portal area and lumen stenosis. Conclusions:CD, ALGS and PFIC are the common causes of genetic and metabolic ICH.Fundamental cause of cholestasis should be actively examined in children with cytomegalovirus infection.High-throughput sequencing is of great significance in the accurate diagnosis of ICH.

Cholestasis, Ichthyosis

A Case of Ichthyosis Follicularis, Atrichia and Photophobia Syndrome Caused by a Novel Mutation in the MBTPS2 Gene

A case of multiple carboxylase deficiency presenting with skin lesions as the initial symptom induced by a novel mutation in the holocarboxylase synthetase gene

[Clinical Features and VPS33B Mutations in a Family Affected by Arthrogryposis, Renal Dysfunction, and Cholestasis Syndrome].

One Case of Arthrogryposis-Renal Dysfunction-Cholestasis (ARC) Syndrome Featuring an Incomplete and Mild Phenotype.

Case Report: Progressive Cholestasis: Severe Phenotype Of Megdel Syndrome With Satb2-Associated Syndrome

Advances in the Study of Familial Intrahepatic Cholestasis

Infantile cholestasis caused by CFTR mutation: case report and literature review

[Intrahepatic Cholestasis Due to Mitochondrial Respiratory Chain Complex I Deficiency in a Chinese Boy].

A case of hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis caused by a mutation in the FAM111B gene

[A case of neonatal liver failure].

Molecular Findings in Children with Inherited Intrahepatic Cholestasis

Two Novel VPS33B Mutations in a Patient with Arthrogryposis, Renal Dysfunction and Cholestasis Syndrome in Mainland China

[Analysis of clinical characteristic of children with progressive familial intrahepatic cholestasis type 3]

[Clinical and Genetic Analysis of a Family Affected by Progressive Familial Intraphepatic Cholestasis Type 3].

Congenital ichthyosis: a multidisciplinary approach in a neonatal care unit

Genetic diagnosis of progressive familial intrahepatic cholestasis type 2

A Novel Compound Heterozygous Mutation in ABCB4 Gene in a Pedigree with Progressive Familial Intrahepatic Cholestasis 3: a Case Report.

Genetic Analysis and Prenatal Diagnosis in a Chinese with Growth Retardation, Abnormal Liver Function, and Microcephaly

Heterozygous deletion in 18q21 causes infantile cholestasis and mental retardation: a case report

Clinical characteristics and high-throughput sequencing analysis of genetic and metabolic infantile cholestatic hepatopathy